TGFBR2 and neoplasm: Conversely, an anti-angiogenic role was identified in CRC where miR-17-92 downregulated angiogenic inducing genes: TGFBR2, HIF1α, and VEGFA [74], and a tumor suppressive role was identified in prostate cancer [75].